Arthneeti
Latest: S H Kelkar & Company Ltd Q2 FY27 (Jul–Sep 2026) results →This page is Q1 FY27 (Apr–Jun 2026).All Q1 FY27 results →
SH

S H Kelkar & Company Ltd

Q1 FY27Chemicals & Petrochemicals

S H Kelkar & Company Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹154
Market cap₹2.4K Cr
P/E50.0
Updated25 Aug 2026
Read4 min read

S H Kelkar & Company Ltd Q1 FY27 key numbers

Revenue
New initiatives in Europe and the USA show traction, aiming for $100 million market capture over next few years.

As stated in S H Kelkar & Company Ltd's Q1 FY27 earnings call transcript · published 25 Aug 2026. Reported figures, not investment advice.

The short version

The company targets double-digit revenue growth for FY 2027, with some quarterly variations expected due to geopolitical and demand timing factors. - Flavours segment achieved Rs. The company targets double-digit revenue growth for FY2027, expecting margins to improve if growth sustains. - Flavour business displayed strong Q1 performance (Rs.

From S H Kelkar & Company Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Moderate growth
  • The company targets double-digit revenue growth for FY 2027, with some quarterly variations expected due to geopolitical and demand timing factors.
  • Flavours segment achieved Rs. 112 crore in Q1, with a normalized run rate estimated around Rs. 95-96 crore from Q2 onwards; growth expected to be strong but not at Q1 levels due to inventory prepayments.
  • Fragrance segment sees growth opportunities, especially in new markets like Europe (Germany), USA, and UK, with expected breakeven in 3 years and subsequent fast growth.
  • New initiatives in Europe and the USA show traction, aiming for $100 million market capture over next few years.
  • Investments in R&D and CDCs to support sustained growth and product innovation.

2 more points from S H Kelkar & Company Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what S H Kelkar & Company Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Completed European capex with the plant operational since May; Rs. 25 crore spent in Europe in Q1 FY27.
  • Ongoing capex in India focusing on Vanvate and Vashivali fragrance projects; Rs. 25 crore planned for Vanvate in Q2 and approximately Rs. 50 crore remaining for three plants in India.
  • Vanvate factory expected to be operational by Q3 FY27.
  • Decision pending on whether the remaining Rs. 25 crore for Vashivali plant upgradation will be spent in Q4 FY27 or deferred to next year.
  • The company is investing roughly $3 million annually in R&D to support growth.

2 more points from S H Kelkar & Company Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what S H Kelkar & Company Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Order book rising
  • In Q1 FY 2027, there was a higher-than-expected sales number in the Flavours segment, partly due to client preponement and extra stock buildup (approx. Rs. 15 crore).
  • This Rs. 15 crore reflects additional inventory rather than final consumption.
  • The base regular orderbook for Flavours is estimated around Rs. 95-97 crore per quarter.
  • Going forward, Q2 and subsequent quarters are expected to normalize with Flavours around Rs. 95-96 crore, potentially slightly higher but not at the Q1 level of Rs. 112 crore.
  • No new segments or large global account orders are currently significant.
  • Business remains normal with double-digit growth overall.
  • USA and UK markets are at early stages; expected minimum revenue from USA is Rs. 1.5 to 2 million for the year.

2 more points from S H Kelkar & Company Ltd's call on order book

Create a free account to keep reading this call

What the Q1 FY27 call signalled

2 of 5 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned
FundraiseNo fundraise planned
Order bookOrder book rising

S H Kelkar & Company Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹650 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What S H Kelkar & Co.'s management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Alufluoride (Q1 FY27)

    Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr

  • POCL Enterprises (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Devson Catalyst (Q1 FY27)

    FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee

  • Ambani Orgochem (Q1 FY27)

    Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

S H Kelkar & Company Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were S H Kelkar & Company Ltd Q1 FY27 results?

The company targets double-digit revenue growth for FY 2027, with some quarterly variations expected due to geopolitical and demand timing factors. - Flavours segment achieved Rs. The company targets double-digit revenue growth for FY2027, expecting margins to improve if growth sustains. - Flavour business displayed strong Q1 performance (Rs.

What is S H Kelkar & Company Ltd share price analysis?

S H Kelkar & Company Ltd currently shows a below-average growth signal. The stock trades at a P/E of 50.0 with a market cap of ₹2,363 Cr. Investors should review the full earnings analysis for detailed insights.

Is S H Kelkar & Company Ltd planning capital expenditure?

Completed European capex with the plant operational since May; Rs.

Keep S H Kelkar & Company Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.